Chrystal Jensen Biography and Net Worth

Insider of Cerus

Ms. Jensen was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Jensen served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Jensen received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.

What is Chrystal Jensen's net worth?: The estimated net worth of Chrystal Jensen is at least $1.07 million as of March 13th, 2024. Ms. Jensen owns 508,736 shares of Cerus stock worth more than $1,068,346 as of December 5th. This net worth evaluation does not reflect any other assets that Ms. Jensen may own. Additionally, Ms. Jensen receives an annual salary of $571,490.00 as Insider at Cerus. Learn More about Chrystal Jensen's net worth.
How old is Chrystal Jensen?: Ms. Jensen is currently 53 years old. There are 5 older executives and no younger executives at Cerus. The oldest executive at Cerus is Dr. Laurence M. Corash M.D., Co-Founder & Chief Scientific Officer, who is 80 years old. Learn More on Chrystal Jensen's age.
What is Chrystal Jensen's salary?: As the Insider of Cerus Corporation, Ms. Jensen earns $571,490.00 per year. There are 5 executives that earn more than Ms. Jensen. The highest earning executive at Cerus is Mr. William M. Greenman, President, CEO & Director, who commands a salary of $1,040,000.00 per year. Learn More on Chrystal Jensen's salary.
How do I contact Chrystal Jensen?: The corporate mailing address for Ms. Jensen and other Cerus executives is 1220 CONCORD AVENUE SUITE 600, CONCORD CA, 94520. Cerus can also be reached via phone at (925) 288-6000 and via email at [email protected]. Learn More on Chrystal Jensen's contact information.
Has Chrystal Jensen been buying or selling shares of Cerus?: Chrystal Jensen has not been actively trading shares of Cerus during the last quarter. Most recently, Chrystal Jensen sold 17,460 shares of the business's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $2.06, for a transaction totalling $35,967.60. Following the completion of the sale, the insider now directly owns 508,736 shares of the company's stock, valued at $1,047,996.16. Learn More on Chrystal Jensen's trading history.
Who are Cerus' active insiders?: Cerus' insider roster includes Richard Benjamin (Chief Medical Officer), Eric Bjerkholt (Director), Laurence Corash (Insider), Kevin Green (CFO), William Greenman (CEO), Vivek Jayaraman (COO), Chrystal Jensen (Insider), Ann Lucena (Director), Chrystal Menard (Insider), Carol Moore (SVP), Gail Schulze (Director), Hua Shan (Director), and Daniel Swisher, Jr. (Director). Learn More on Cerus' active insiders.
Are insiders buying or selling shares of Cerus?: In the last year, insiders at the biotechnology company sold shares 13 times. They sold a total of 461,150 shares worth more than $700,809.60. The most recent insider tranaction occured on March, 13th when COO Vivek K Jayaraman sold 29,985 shares worth more than $43,478.25. Insiders at Cerus own 5.6% of the company. Learn More about insider trades at Cerus.
Information on this page was last updated on 3/13/2025.

Chrystal Jensen Insider Trading History at Cerus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/13/2024	Sell	17,460	$2.06	$35,967.60	508,736

Chrystal Jensen Buying and Selling Activity at Cerus

Cerus Company Overview

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Today's Range

Now: $2.10

$1.96

$2.11

50 Day Range

MA: $1.60

$1.40

$2.10

2 Week Range

Now: $2.10

$1.12

$2.24

Volume

1,534,120 shs

Average Volume

1,403,832 shs

Market Capitalization

$403.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Chrystal Jensen Biography and Net Worth

What is Chrystal Jensen's net worth?

How old is Chrystal Jensen?

What is Chrystal Jensen's salary?

How do I contact Chrystal Jensen?

Has Chrystal Jensen been buying or selling shares of Cerus?

Who are Cerus' active insiders?

Are insiders buying or selling shares of Cerus?